Weight loss jabs may cut heart risk in people with type 2 diabetes, especially when combined with healthy lifestyle habits,...
Czech company H₂ Medical Technologies, a subsidiary of H₂ Global Group, has received official approval from the State Institute for Drug Control (SÚKL) to begin a...
Canada has conditionally approved Leqembi (lecanemab), the first treatment that targets an underlying cause of early Alzheimer’s disease by removing toxic amyloid beta proteins from the...
Swapping just 30 minutes of sitting for light activity, such as walking or housework, can improve mood and energy the following day, new research suggests. A...
Bright light at night raises the risk of heart attack by 47 per cent and heart failure by 56 per cent, according to research involving nearly...
Generation Lab has raised US$11m to expand its SystemAge platform for ageing diagnostics and clinic rollout, less than a year after launch. The seed round, led...
Semaglutide reduces the risk of heart attack and stroke by 20 per cent, regardless of weight lost, according to the largest study of 17,604 patients. The...
